MedPath

TILAK HEALTHCARE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY

Active, not recruiting
Conditions
Impaired Visual Acuity
First Posted Date
2023-10-11
Last Posted Date
2023-11-07
Lead Sponsor
Tilak Healthcare
Target Recruit Count
300
Registration Number
NCT06076785
Locations
🇫🇷

Centre Ophtalmologique Oculus, Chambéry, Auvergne Rhône Alpes, France

🇫🇷

Clinique Mathilde, Rouen, Normandie, France

🇫🇷

SELARL Dr Boulet, Évreux, Normandie, France

and more 5 locations

Post-market Evaluation of OdySight App to Monitor Near Visual Acuity at Home (TIL002)

Completed
Conditions
Visual Impairment
First Posted Date
2022-08-22
Last Posted Date
2022-08-22
Lead Sponsor
Tilak Healthcare
Target Recruit Count
58
Registration Number
NCT05510479
Locations
🇫🇷

Centre Hospitalier National d'Ophtahlomogie du Quinze-Vingts, Paris, Ile-de-France, France

🇫🇷

Centre Ophtalmologique Rabelais, Lyon, France

🇫🇷

Institut Ophtalmologique de l'Ouest Clinique Jules Verne, Nantes, France

Evaluation of Near Visual Acuity With ODYSIGHT, a Smartphone Based Medical App in Comparison to a Standardized Method

Not Applicable
Completed
Conditions
Near Vision
First Posted Date
2018-03-07
Last Posted Date
2018-07-27
Lead Sponsor
Tilak Healthcare
Target Recruit Count
120
Registration Number
NCT03457441
Locations
🇫🇷

Centre Hospitalier National d'Ophtahlomogie du Quinze-Vingts, Paris, Ile-de-France, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.